Literature DB >> 3834641

[Borna virus infection (Borna disease) in naturally and experimentally infected animals: its significance for research and practice].

H Ludwig, W Kraft, M Kao, G Gosztonyi, E Dahme, H Krey.   

Abstract

In this survey article on Borna Disease-many years after the review of Zwick (1939)-again a modern comprehensive summary of "Borna Disease virus infection" is given. The infection occurs in horses and sheep, furthermore, in laboratory animal species inoculated experimentally; its clinical, virological and neuropathological features have been described in numerous presentations. Clinical symptoms in naturally and experimentally infected animals are characterized by initial alterations in the sensorium. The neurological symptomatology of the disease (disturbances in coordination, motor, sensory and vegetative symptoms) reflect the presumed localisation of the virus in various brain areas and the course of the disease supports the assumption of intraneural spread of the agent. In horses the incidence is highest during spring. Experimental infections show an exceptionally broad spectrum of infectible animals extending from higher mammals to birds. Our investigations make it clear that we have to differentiate between infections followed by disease (e.g. horse, rabbit, older rat) and persistent infections without overt clinical symptoms (mouse, chicken). Persistent infections are sometimes associated with fine alterations in behaviour (tree shrew) or decreased learning ability (mice). Borna Disease virus, which has not been characterized up to now, is known to grow without any cytopathic effect in tissue cultures. All tested cell lines (including those from man) could be infected. The investigations indicate that Borna Disease virus comprises an enveloped RNS-containing agent. The infection induces the production of specific antigens such as a complex known as the soluble antigen, and a 14500 dalton protein. Under natural conditions and in experimentally infected animals antibodies are produced against such soluble proteins and determinants involved in neutralization of the virus. In the central nervous system (CNS) a local immune response accompanied by the production of oligoclonal immunoglobulins is demonstrable. Besides the humoral reaction it was possible to study the influence of cellular defence mechanisms on the disease process in monkeys, rats and rabbits. Histopathologically, Borna Disease is characterized by a non-purulent inflammation of the brain and the spinal cord. Most alterations are found in the grey matter, mainly in the Ammon's horn, olfactory lobe, caudate nucleus, thalamus, lamina quadrigemina and in he cerebellar nuclei. The perivascular infiltrations, consisting of lymphocytes, histiocytes and plasma cells are most conspicuous. Occasionally, degenerative alterations are observed in ganglion cells.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3834641

Source DB:  PubMed          Journal:  Tierarztl Prax        ISSN: 0303-6286


  18 in total

1.  Isolation and characterization of Borna disease agent cDNA clones.

Authors:  W I Lipkin; G H Travis; K M Carbone; M C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Characterization of the Borna disease virus phosphoprotein, p23.

Authors:  S Kliche; L Stitz; H Mangalam; L Shi; T Binz; H Niemann; T Briese; W I Lipkin
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Pathogenesis of Borna disease in rats: evidence that intra-axonal spread is the major route for virus dissemination and the determinant for disease incubation.

Authors:  K M Carbone; C S Duchala; J W Griffin; A L Kincaid; O Narayan
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

4.  High prevalence of Borna disease virus infection in healthy sheep in Japan.

Authors:  K Hagiwara; S Kawamoto; H Takahashi; Y Nakamura; T Nakaya; T Hiramune; C Ishihara; K Ikuta
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 5.  Borna disease virus infection, a human mental-health risk.

Authors:  Liv Bode; Hans Ludwig
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

6.  Demonstration of Borna disease virus-specific RNA in secretions of naturally infected horses by the polymerase chain reaction.

Authors:  J A Richt; S Herzog; K Haberzettl; R Rott
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

7.  Neutralizing antibodies in Borna disease virus-infected rats.

Authors:  C G Hatalski; S Kliche; L Stitz; W I Lipkin
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Description of feline nonsuppurative meningoencephalomyelitis ("staggering disease") and studies of its etiology.

Authors:  N Nowotny; H Weissenböck
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

9.  Detection of Borna disease virus RNA in formalin-fixed, paraffin-embedded brain tissues by nested PCR.

Authors:  I Sorg; A Metzler
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

10.  Use of avian bornavirus isolates to induce proventricular dilatation disease in conures.

Authors:  Patricia Gray; Sharman Hoppes; Paulette Suchodolski; Negin Mirhosseini; Susan Payne; Itamar Villanueva; H L Shivaprasad; Kirsi S Honkavuori; W Ian Lipkin; Thomas Briese; Sanjay M Reddy; Ian Tizard
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.